Litigation Details for BOEHRINGER INGELHEIM PHARMACEUTICALS INC. v. SUN PHARMACEUTICAL INDUSTRIES LTD (D.N.J. 2016)
✉ Email this page to a colleague
BOEHRINGER INGELHEIM PHARMACEUTICALS INC. v. SUN PHARMACEUTICAL INDUSTRIES LTD (D.N.J. 2016)
| Docket | ⤷ Sign Up | Date Filed | 2016-03-29 |
| Court | District Court, D. New Jersey | Date Terminated | 2016-04-19 |
| Cause | 35:271 Patent Infringement | Assigned To | Peter G. Sheridan |
| Jury Demand | None | Referred To | Tonianne J. Bongiovanni |
| Patents | 9,173,859 | ||
| Link to Docket | External link to docket | ||
Details for BOEHRINGER INGELHEIM PHARMACEUTICALS INC. v. SUN PHARMACEUTICAL INDUSTRIES LTD (D.N.J. 2016)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 0000-00-00 | External link to document | |||
| 2016-03-29 | 1 | U.S. Patent No. 9,173,859 27. On November 3, 2015, the U.S. Patent and Trademark Office…and legally issued United States Patent No. 9,173,859 (“the ‟859 patent”) entitled “Uses of DPP-IV Inhibitors…prior to the expiration of United States Patent No. 9,173,859. …is an action for patent infringement arising under the Food and Drug Laws and Patent Laws of the United…the ‟859 patent, within the United States, prior to the expiration of that patent, including any | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
